Skip to main content
Clinical Trials/IRCT20201007048955N1
IRCT20201007048955N1Not yet recruiting未知

Evaluation the efficacy of autologous platelet rich plasma (PRP) in prevention of hypertrophic scar at the site of sternotomy in adults with open heart surgery in Shahid Modarres Hospital in 2020-2021

Clinical Research Development Center0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Not having diabetes
  • Not having autoimmune diseases
  • Not having thrombocytopenia(platelets below 150000)
  • Not receiving glucocorticoids

Exclusion Criteria

  • Patient not referring to the doctor for surveillance
  • Death of the patient during the surveillance period

Investigators

Sponsor
Clinical Research Development Center

Similar Trials

Efficacy of autologous platelet rich... | Clinical Trial